Biopharmaceutical Manufacturing

Predefined Single-Use Production Platforms for Biomanufacturing

The biopharmaceutical industry can reduce the time and cost required to bring products to the clinic and the market by taking advantage of single-use production platforms. These platforms integrate proven services and technologies for the development and manufacture of mAbs, vaccines, and bioconjugates.

Companies can streamline early-stage process development activities by leveraging the expertise and experience Sartorius has acquired over many years while establishing biomanufacturing processes for clients. Furthermore, Sartorius can expedite the engineering of single-use and hybrid processes for scale-up during late-stage activities using process templates that reduce design costs and increase standardization.

Racing for a Viable Vaccine: Expediting Vaccine Development Amidst a Pandemic
Fight the Coronavirus

Sartorius Biomanufacturing Platforms

Vaccines

Learn More

Blood and Plasma

Learn More

Bioconjugation

Learn More

Regenerative Medicine

Learn More

Biosimilars

Learn More

Intensified Processing

Learn More
Publication: A Look into the Future of Bioprocessing
Download Now

Explore Sartorius

Bioprocess Development Engineering

Learn More

Expert Voice, Publications and Case Studies

Learn More

Sartorius Application Center

Learn More